Propafenone: Clinical Trials

28 trials of Propafenone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 9 unknown, 2 terminated, 1 active not recruiting. 11 Not applicable, 7 Phase 4, 5 Phase 3, 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 5, Unknown 4, Active not recruiting 1, Withdrawn 1
Phase 47Unknown 4, Completed 2, Not yet recruiting 1
Phase 35Completed 3, Suspended 1, Terminated 1
Phase 13Completed 2, Terminated 1
Phase 22Completed 1, Terminated 1

Follow this drug Literature Review of Propafenone trials Research Report on Propafenone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dronedarone Rhythm Intervention for Early Atrial Fibrillation
Dronedarone, flecainide, propafenone - Atrial Fibrillation (AF)
Phase 4Not yet recruitingInha University Hospital18982026-01-012025-12-22
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
FARAPULSE™ Pulsed Field Ablation (PFA) System, Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone - Persistent Atrial Fibrillation
Not applicableActive not recruitingBoston Scientific Corporation4842023-12-282026-08-28
Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.
Antazoline, Propafenone - Atrial Fibrillation
Phase 4UnknownCentre of Postgraduate Medical Education1052019-09-012023-02-14
Efficacy and Safety of Sotalol in Children With Arrhythmia
sotalol, Propafenone, betaloc - Arrhythmia
Phase 4UnknownShengjing Hospital5002019-08-012019-03-29
Propafenone in the Treatment of Atrial Fibrillation
Propafenone - Atrial Fibrillation
Not applicableCompletedTSH Biopharm Corporation Limited712019-07-112021-09-23
Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions
Propafenone, Rytmonorm - Bioequivalence
Phase 1CompletedPharmtechnology LLC322019-03-232019-06-06
Population Pharmacokinetics of Propafenone and Propranolol in Children Patients
Propafenone and Propranolol - Arrhythmia
UnknownShandong University5002019-02-012022-07-19
Early Aggressive Invasive Intervention for Atrial Fibrillation
Cryoballoon-based PVI, Anti-Arrhythmic Drug Therapy - Atrial Fibrillation
Not applicableUnknownJason Andrade3032017-01-012022-10-10
New Formulations of Propafenone to Treat Atrial Fibrillation
(R)-propafenone, (S)-Propafenone, Placebo - Atrial Fibrillation
Phase 1 / Phase 2TerminatedVanderbilt University1932016-10-012022-06-03
Comparison of Brain Perfusion in Rhythm Control and Rate Control of Persistent Atrial Fibrillation
Propafenone, Apixaban - Persistent Atrial Fibrillation
Not applicableUnknownYonsei University2002015-11-012019-01-28
Beta-blocker vs. Ic Antiarrhythmic Drug for PVC
Propafenone, Indenol - Premature Ventricular Complex
Not applicableWithdrawnYong Seog Oh2015-06-012024-04-23
Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation
AVATAR-AF ablation, Anti-Arrhythmic therapy, Conventional AF ablation - Heart Failure, Recurrent Atrial Fibrillation
Not applicableCompletedImperial College London3212015-05-012024-10-09
A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent AF
single ablation (CryoBalloonAblation (CBA), sequential drug adjustment (propafenone, sotalol or flecainide) - Atrial Fibrillation
Phase 4CompletedUniversity Hospital, Ghent132015-03-032023-08-01
Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation
Amiodarone, Propafenone, Sotalol - Atrial Fibrillation
Phase 4UnknownXinhua Hospital, Shanghai Jiao Tong University School of Medicine6002014-05-012014-05-23
Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias
antiarrhythmic drugs (Flecainide or Propafenone or Sotalol), Catheter Ablation - Ventricular Tachycardia, Ventricular Premature Complexes
Phase 4UnknownOspedale San Donato2013-01-012013-01-31
Efficacy of Pilsicainide After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation
pilsicainide, other class IC antiarrhythmic drug - Paroxysmal Atrial Fibrillation
Not applicableUnknownKorea University2452012-07-012013-02-26
Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites
Propafenone - Arrhythmia, Cardiac
Phase 1CompletedGlaxoSmithKline382012-04-112017-06-12
Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
Propafenone, Dronedarone - Atrial Fibrillation
Not applicableCompletedSamsung Medical Center982011-05-012013-11-25
Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation (CAPTAF Trial)
Catheterablation, Amiodarone, Sotalol - Atrial Fibrillation, Quality of Life
Not applicableUnknownUppsala University Hospital1522008-05-012017-05-09
AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study
FDA approved rate and rhythm control drugs, AV Node ablation and device implant - Atrial Fibrillation, Heart Failure
Phase 3TerminatedMayo Clinic272007-12-012013-04-04

Showing 20 of 28. Sign in to see all of them.

Conditions studied

Atrial Fibrillation (22)  ·  Arrhythmias, Cardiac (7)  ·  Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Heart Failure (2)  ·  Ventricular Premature Complexes (2)  ·  Heart Arrest (1)  ·  Myocardial Infarction (1)  ·  Tachycardia, Ventricular (1)  ·  Ventricular Fibrillation (1)

Sponsors

Biosense Webster, Inc. (1)  ·  Boston Scientific Corporation (1)  ·  Centre of Postgraduate Medical Education (1)  ·  GlaxoSmithKline (1)  ·  Imperial College London (1)  ·  Inha University Hospital (1)  ·  Jason Andrade (1)  ·  Korea University (1)  ·  Mayo Clinic (1)  ·  Medtronic Cardiac Rhythm and Heart Failure (1)  ·  Meshalkin Research Institute of Pathology of Circulation (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  Ospedale San Donato (1)  ·  Pharmtechnology LLC (1)  ·  ProRhythm, Inc. (1)

Countries

United States (8)  ·  Canada (5)  ·  South Korea (5)  ·  China (3)  ·  Italy (3)  ·  Belgium (2)  ·  France (2)  ·  Taiwan (2)  ·  Australia (1)  ·  Austria (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Poland (1)

Top investigators

H. Greene (2)  ·  Ben Shoemaker, MD (1)  ·  Bjorn Knollmann, MD/PhD (1)  ·  Douglas L. Packer, MD (1)  ·  Dr. Prapa Kanagaratnam (1)  ·  Edward P. Gerstenfeld, MD (1)  ·  Eric Sicard, MD (1)  ·  Evgeny Pokushalov, MD, PhD (1)  ·  Hugh Calkins, MD (1)  ·  Jason Andrade, M.D. (1)  ·  Luc Jordaens, MD, PhD (1)  ·  Oussama Wazni, M.D. (1)

Results publications

PMID 19029470, PMID 19738139, PMID 21076158, PMID 21422032, PMID 22032709, PMID 23500312, PMID 23748210, PMID 25134972, PMID 28974568, PMID 30342299, PMID 31152874, PMID 33197159, PMID 36166682, PMID 36342178, PMID 36576323, PMID 36800262, PMID 37018501, PMID 38007219, PMID 42041224, PMID 42774368

NIH funding

2008 (1), R01HL031472 (1), R01HL124935 (1)